-
1
-
-
0030445353
-
Psoriasis of the nails associated with disability in a large number of patients: Results of a recent interview with 1,728 patients
-
De Jong EM, Seegers BA, Gulinck MK, Boezeman JB, Van De Kerkhof PC. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology. 1996;193:300- 303.
-
(1996)
Dermatology
, vol.193
, pp. 300-303
-
-
De Jong, E.M.1
Seegers, B.A.2
Gulinck, M.K.3
Boezeman, J.B.4
Van De Kerkhof, P.C.5
-
2
-
-
34250204897
-
Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy
-
DOI 10.1016/j.jaad.2005.07.073, PII S0190962205032287
-
Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol. 2007;57:1-27. (Pubitemid 46899261)
-
(2007)
Journal of the American Academy of Dermatology
, vol.57
, Issue.1
, pp. 1-27
-
-
Jiaravuthisan, M.M.1
Sasseville, D.2
Vender, R.B.3
Murphy, F.4
Muhn, C.Y.5
-
4
-
-
69049113992
-
Approach to managing patients with nail psoriasis
-
Reich K. Approach to managing patients with nail psoriasis. J Eur Acad Dermatol Venereol 2009;23:15-21.
-
(2009)
J Eur Acad Dermatol Venereol
, vol.23
, pp. 15-21
-
-
Reich, K.1
-
5
-
-
63049083901
-
Management of psoriatic nail disease
-
De BD. Management of psoriatic nail disease. Semin Cutan Med Surg. 2009;28:39-43.
-
(2009)
Semin Cutan Med Surg
, vol.28
, pp. 39-43
-
-
De, B.D.1
-
6
-
-
70449379640
-
Psoriatic nail disease: Quality of life and treatment
-
Gupta AK, Cooper EA. Psoriatic nail disease: quality of life and treatment. J Cutan Med Surg. 2009;13:S102-S106.
-
(2009)
J Cutan Med Surg
, vol.13
-
-
Gupta, A.K.1
Cooper, E.A.2
-
7
-
-
34147106954
-
Biological therapy and nail psoriasis
-
DOI 10.1111/j.1529-8019.2007.00112.x
-
Lawry M. Biological therapy and nail psoriasis. Dermatol Ther. 2007;20:60-67. (Pubitemid 46568378)
-
(2007)
Dermatologic Therapy
, vol.20
, Issue.1
, pp. 60-67
-
-
Lawry, M.1
-
8
-
-
79954622167
-
Infliximab efficacy in nail psoriasis. A retrospective study in 48 patients
-
Fabroni C, Gori A, Troiano M, Prignano F, Lotti T. Infliximab efficacy in nail psoriasis. A retrospective study in 48 patients. J Eur Acad Dermatol Venereol. 2010;25(5):549- 553.
-
(2010)
J Eur Acad Dermatol Venereol
, vol.25
, Issue.5
, pp. 549-553
-
-
Fabroni, C.1
Gori, A.2
Troiano, M.3
Prignano, F.4
Lotti, T.5
-
9
-
-
72449136160
-
Marked improvement in nail psoriasis during treatment with adalimumab
-
Irla N, Yawalkar N. Marked improvement in nail psoriasis during treatment with adalimumab. Dermatology 2009;219: 353-356.
-
(2009)
Dermatology
, vol.219
, pp. 353-356
-
-
Irla, N.1
Yawalkar, N.2
-
10
-
-
67651148328
-
Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate- to-severe psoriasis
-
Luger TA, Barker J, Lambert J, Yang S, Robertson D, Foehl J, et al. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate- to-severe psoriasis. J Eur Acad Dermatol Venereol. 2009; 23:896-904.
-
(2009)
J Eur Acad Dermatol Venereol
, vol.23
, pp. 896-904
-
-
Luger, T.A.1
Barker, J.2
Lambert, J.3
Yang, S.4
Robertson, D.5
Foehl, J.6
-
11
-
-
78349273658
-
Ustekinumab for rapid treatment of nail psoriasis
-
Rallis E, Kintzoglou S, Verros C. Ustekinumab for rapid treatment of nail psoriasis. Arch Dermatol. 2010;146:1315- 1316.
-
(2010)
Arch Dermatol
, vol.146
, pp. 1315-1316
-
-
Rallis, E.1
Kintzoglou, S.2
Verros, C.3
-
12
-
-
77956343215
-
Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: A retrospective analysis of the EXPRESS Trial
-
Reich K, Ortonne JP, Kerkmann U, Wang Y, Saurat JH, Papp K, et al. Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial. Dermatology. 2010;221:172-178.
-
(2010)
Dermatology
, vol.221
, pp. 172-178
-
-
Reich, K.1
Ortonne, J.P.2
Kerkmann, U.3
Wang, Y.4
Saurat, J.H.5
Papp, K.6
-
13
-
-
38349097035
-
Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year
-
Rich P, Griffiths CE, Reich K, Nestle FO, Scher RK, Li S, et al. Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol. 2008;58:224-231.
-
(2008)
J Am Acad Dermatol
, vol.58
, pp. 224-231
-
-
Rich, P.1
Griffiths, C.E.2
Reich, K.3
Nestle, F.O.4
Scher, R.K.5
Li, S.6
-
14
-
-
79954621230
-
Nail psoriasis: A retrospective study on the effectiveness of systemic treatments (classical and biological therapy)
-
Sanchez-Regana M, Sola-Ortigosa J, Alsina-Gibert M, Vidal-Fernandez M, Umbert-Millet P. Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy). J Eur Acad Dermatol Venereol. 2010;25(5):579-586.
-
(2010)
J Eur Acad Dermatol Venereol
, vol.25
, Issue.5
, pp. 579-586
-
-
Sanchez-Regana, M.1
Sola-Ortigosa, J.2
Alsina-Gibert, M.3
Vidal-Fernandez, M.4
Umbert-Millet, P.5
-
15
-
-
77950847886
-
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease
-
Marchesoni A, Altomare G, Matucci-Cerinic M, Balato N, Olivieri I, Salvarani C, et al. An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease. J Eur Acad Dermatol Venereol. 2010;24: 578-586.
-
(2010)
J Eur Acad Dermatol Venereol
, vol.24
, pp. 578-586
-
-
Marchesoni, A.1
Altomare, G.2
Matucci-Cerinic, M.3
Balato, N.4
Olivieri, I.5
Salvarani, C.6
-
16
-
-
0042133222
-
Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis
-
DOI 10.1067/S0190-9622(03)00910-1
-
Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003;49: 206-212. (Pubitemid 36951265)
-
(2003)
Journal of the American Academy of Dermatology
, vol.49
, Issue.2
, pp. 206-212
-
-
Rich, P.1
Scher, R.K.2
-
17
-
-
33846909827
-
Interobserver reliability of the nail psoriasis severity index
-
DOI 10.1111/j.1365-2230.2006.02305.x
-
Aktan S, Ilknur T, Akin C, Ozkan S. Interobserver reliability of the Nail Psoriasis Severity Index. Clin Exp Dermatol. 2007; 32:141-144. (Pubitemid 46233014)
-
(2007)
Clinical and Experimental Dermatology
, vol.32
, Issue.2
, pp. 141-144
-
-
Aktan, S.1
Ilknur, T.2
Akin, C.3
Ozkan, S.4
-
18
-
-
38349063393
-
The comparison of nail psoriasis severity index with a less time-consuming qualitative system
-
Kacar N, Ergin S, Erdogan BS. The comparison of nail psoriasis severity index with a less time-consuming qualitative system. J Eur Acad Dermatol Venereol. 2008;22: 219-222.
-
(2008)
J Eur Acad Dermatol Venereol
, vol.22
, pp. 219-222
-
-
Kacar, N.1
Ergin, S.2
Erdogan, B.S.3
-
19
-
-
67649331684
-
Ustekinumab: A new option in psoriasis therapy
-
Chien AL, Elder JT, Ellis CN. Ustekinumab: a new option in psoriasis therapy. Drugs. 2009;69:1141-1152.
-
(2009)
Drugs
, vol.69
, pp. 1141-1152
-
-
Chien, A.L.1
Elder, J.T.2
Ellis, C.N.3
-
20
-
-
57749184069
-
Etanercept in the treatment and retreatment of psoriasis in daily clinical practice
-
Barrera MV, Habicheyn S, Mendiola MV, Herrera CE. Etanercept in the treatment and retreatment of psoriasis in daily clinical practice. Eur J Dermatol. 2008;18:683-687.
-
(2008)
Eur J Dermatol
, vol.18
, pp. 683-687
-
-
Barrera, M.V.1
Habicheyn, S.2
Mendiola, M.V.3
Herrera, C.E.4
-
21
-
-
33748936662
-
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study
-
DOI 10.1016/j.jaad.2006.05.027, PII S019096220601499X
-
Gordon KB, Langley RG, Leonardi C, Toth D, Menter MA, Kang S, et al. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study. J Am Acad Dermatol. 2006;55:598-606. (Pubitemid 44436647)
-
(2006)
Journal of the American Academy of Dermatology
, vol.55
, Issue.4
, pp. 598-606
-
-
Gordon, K.B.1
Langley, R.G.2
Leonardi, C.3
Toth, D.4
Menter, M.A.5
Kang, S.6
Heffernan, M.7
Miller, B.8
Hamlin, R.9
Lim, L.10
Zhong, J.11
Hoffman, R.12
Okun, M.M.13
-
22
-
-
75749091855
-
Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions
-
Van den Bosch F, Manger B, Goupille P, McHugh N, Rodevand E, Holck P, et al. Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann Rheum Dis. 2010;69:394-399.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 394-399
-
-
Van Den Bosch, F.1
Manger, B.2
Goupille, P.3
McHugh, N.4
Rodevand, E.5
Holck, P.6
-
23
-
-
26644433889
-
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trial
-
DOI 10.1016/S0140-6736(05)67566-6, PII S0140673605675666
-
Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet. 2005;366:1367-1374. (Pubitemid 41443403)
-
(2005)
Lancet
, vol.366
, Issue.9494
, pp. 1367-1374
-
-
Reich, K.1
Nestle, F.O.2
Papp, K.3
Ortonne, J.-P.4
Evans, R.5
Guzzo, C.6
Li, S.7
Dooley, L.T.8
Griffiths, C.E.M.9
-
24
-
-
47549099185
-
Evaluation of the efficacy and safety of infliximab on psoriatic nails: An unblinded, nonrandomized, open-label study
-
DOI 10.1111/j.1365-2133.2008.08686.x
-
Rigopoulos D, Gregoriou S, Stratigos A, Larios G, Korfitis C, Papaioannou D, et al. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study. Br J Dermatol. 2008;159:453- 456. (Pubitemid 352009870)
-
(2008)
British Journal of Dermatology
, vol.159
, Issue.2
, pp. 453-456
-
-
Rigopoulos, D.1
Gregoriou, S.2
Stratigos, A.3
Larios, G.4
Korfitis, C.5
Papaioannou, D.6
Antoniou, C.7
Ioannides, D.8
-
25
-
-
33846889522
-
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis
-
DOI 10.1056/NEJMoa062382
-
Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, Wang Y, et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med. 2007;356: 580-592. (Pubitemid 46220818)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.6
, pp. 580-592
-
-
Krueger, G.G.1
Langley, R.G.2
Leonardi, C.3
Yeilding, N.4
Guzzo, C.5
Wang, Y.6
Dooley, L.T.7
Lebwohl, M.8
-
26
-
-
43449111187
-
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
-
DOI 10.1016/S0140-6736(08)60725-4, PII S0140673608607254
-
Leonardi CL, Kimball AB, Papp KA, Yeilding N, Guzzo C, Wang Y, et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet. 2008;371: 1665-1674. (Pubitemid 351671883)
-
(2008)
The Lancet
, vol.371
, Issue.9625
, pp. 1665-1674
-
-
Leonardi, C.L.1
Kimball, A.B.2
Papp, K.A.3
Yeilding, N.4
Guzzo, C.5
Wang, Y.6
Li, S.7
Dooley, L.T.8
Gordon, K.B.9
-
27
-
-
43449139402
-
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
-
DOI 10.1016/S0140-6736(08)60726-6, PII S0140673608607266
-
Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, Yeilding N, et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet. 2008;371: 1675-1684. (Pubitemid 351671884)
-
(2008)
The Lancet
, vol.371
, Issue.9625
, pp. 1675-1684
-
-
Papp, K.A.1
Langley, R.G.2
Lebwohl, M.3
Krueger, G.G.4
Szapary, P.5
Yeilding, N.6
Guzzo, C.7
Hsu, M.-C.8
Wang, Y.9
Li, S.10
Dooley, L.T.11
Reich, K.12
|